Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Overcoming T cell exhaustion in infection and cancer
Kristen E. Pauken, E. John Wherry
Trends in Immunology (2015) Vol. 36, Iss. 4, pp. 265-276
Open Access | Times Cited: 990

Showing 1-25 of 990 citing articles:

Understanding the tumor immune microenvironment (TIME) for effective therapy
Mikhail Binnewies, Edward W. Roberts, Kelly Kersten, et al.
Nature Medicine (2018) Vol. 24, Iss. 5, pp. 541-550
Open Access | Times Cited: 4450
Molecular and cellular insights into T cell exhaustion
E. John Wherry, Makoto Kurachi
Nature reviews. Immunology (2015) Vol. 15, Iss. 8, pp. 486-499
Open Access | Times Cited: 3719
Lag-3, Tim-3, and TIGIT: Co-inhibitory Receptors with Specialized Functions in Immune Regulation
Ana C. Anderson, Nicole Joller, Vijay K. Kuchroo
Immunity (2016) Vol. 44, Iss. 5, pp. 989-1004
Open Access | Times Cited: 1816
Single-Cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment
Elham Azizi, Ambrose Carr, George Plitas, et al.
Cell (2018) Vol. 174, Iss. 5, pp. 1293-1308.e36
Open Access | Times Cited: 1687
The diverse functions of the PD1 inhibitory pathway
Arlene H. Sharpe, Kristen E. Pauken
Nature reviews. Immunology (2017) Vol. 18, Iss. 3, pp. 153-167
Closed Access | Times Cited: 1567
CD8 T Cell Exhaustion During Chronic Viral Infection and Cancer
Laura M. McLane, Mohamed S. Abdel-Hakeem, E. John Wherry
Annual Review of Immunology (2019) Vol. 37, Iss. 1, pp. 457-495
Open Access | Times Cited: 1491
T-cell invigoration to tumour burden ratio associated with anti-PD-1 response
Alexander C. Huang, Michael A. Postow, Robert J. Orlowski, et al.
Nature (2017) Vol. 545, Iss. 7652, pp. 60-65
Open Access | Times Cited: 1477
T cell costimulatory receptor CD28 is a primary target for PD-1–mediated inhibition
Enfu Hui, Jeanne Cheung, Jing Zhu, et al.
Science (2017) Vol. 355, Iss. 6332, pp. 1428-1433
Open Access | Times Cited: 1393
Comprehensive review of targeted therapy for colorectal cancer
Yuanhong Xie, Yingxuan Chen, Jing‐Yuan Fang
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 1313
TOX transcriptionally and epigenetically programs CD8+ T cell exhaustion
Omar Khan, Josephine R. Giles, Sierra McDonald, et al.
Nature (2019) Vol. 571, Iss. 7764, pp. 211-218
Open Access | Times Cited: 1195
Bystander CD8+ T cells are abundant and phenotypically distinct in human tumour infiltrates
Yannick Simoni, Étienne Becht, Michael Fehlings, et al.
Nature (2018) Vol. 557, Iss. 7706, pp. 575-579
Closed Access | Times Cited: 1134
Tumor Interferon Signaling Regulates a Multigenic Resistance Program to Immune Checkpoint Blockade
Joseph L. Benci, Bihui Xu, Yu Qiu, et al.
Cell (2016) Vol. 167, Iss. 6, pp. 1540-1554.e12
Open Access | Times Cited: 975
Dysfunctional CD8 T Cells Form a Proliferative, Dynamically Regulated Compartment within Human Melanoma
Hanjie Li, Anne M. van der Leun, Ido Yofe, et al.
Cell (2018) Vol. 176, Iss. 4, pp. 775-789.e18
Open Access | Times Cited: 939
T-cell exhaustion in the tumor microenvironment
Yuyong Jiang, Yongsheng Li, Bo Zhu
Cell Death and Disease (2015) Vol. 6, Iss. 6, pp. e1792-e1792
Open Access | Times Cited: 894
Rescue of exhausted CD8 T cells by PD-1–targeted therapies is CD28-dependent
Alice O. Kamphorst, Andreas Wieland, Tahseen H. Nasti, et al.
Science (2017) Vol. 355, Iss. 6332, pp. 1423-1427
Open Access | Times Cited: 867
Proliferation of PD-1+ CD8 T cells in peripheral blood after PD-1–targeted therapy in lung cancer patients
Alice O. Kamphorst, Rathi N. Pillai, Shu Yang, et al.
Proceedings of the National Academy of Sciences (2017) Vol. 114, Iss. 19, pp. 4993-4998
Open Access | Times Cited: 748
Co-expression of CD39 and CD103 identifies tumor-reactive CD8 T cells in human solid tumors
Thomas Duhen, Rebekka Duhen, Ryan Montler, et al.
Nature Communications (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 746
Phagocytosis checkpoints as new targets for cancer immunotherapy
Mingye Feng, Wen Jiang, Betty Y.S. Kim, et al.
Nature reviews. Cancer (2019) Vol. 19, Iss. 10, pp. 568-586
Open Access | Times Cited: 744
Toward personalized treatment approaches for non-small-cell lung cancer
Meina Wang, Roy S. Herbst, Chris Boshoff
Nature Medicine (2021) Vol. 27, Iss. 8, pp. 1345-1356
Closed Access | Times Cited: 700
The Tumor Microenvironment Represses T Cell Mitochondrial Biogenesis to Drive Intratumoral T Cell Metabolic Insufficiency and Dysfunction
Nicole E. Scharping, Ashley V. Menk, Rebecca S. Moreci, et al.
Immunity (2016) Vol. 45, Iss. 3, pp. 701-703
Open Access | Times Cited: 641
CRISPR/Cas9-mediated PD-1 disruption enhances anti-tumor efficacy of human chimeric antigen receptor T cells
Levi J. Rupp, Kathrin Schumann, Kole T. Roybal, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 640
The Tumor Microenvironment Represses T Cell Mitochondrial Biogenesis to Drive Intratumoral T Cell Metabolic Insufficiency and Dysfunction
Nicole E. Scharping, Ashley V. Menk, Rebecca S. Moreci, et al.
Immunity (2016) Vol. 45, Iss. 2, pp. 374-388
Open Access | Times Cited: 628
Follicular CXCR5-expressing CD8+ T cells curtail chronic viral infection
Ran He, Shiyue Hou, Cheng Liu, et al.
Nature (2016) Vol. 537, Iss. 7620, pp. 412-416
Closed Access | Times Cited: 611
MHC proteins confer differential sensitivity to CTLA-4 and PD-1 blockade in untreated metastatic melanoma
Scott J. Rodig, Daniel Gusenleitner, Donald Jackson, et al.
Science Translational Medicine (2018) Vol. 10, Iss. 450
Open Access | Times Cited: 512
Resistance to PD1/PDL1 checkpoint inhibition
Jake S. O’Donnell, Georgina V. Long, Richard A. Scolyer, et al.
Cancer Treatment Reviews (2016) Vol. 52, pp. 71-81
Closed Access | Times Cited: 502
Page 1 - Next Page

Scroll to top